- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Stakeholders Provide Insight on the Oncology Care Model
Payers, oncologists, and oncology policy experts provide their feedback on the Oncology Care Model developed by the Centers for Medicare and Medicaid Innovation, which aims to link payment to the quality of care, improve access to care, and enhance information sharing.
In February, the Centers for Medicare and Medicaid Services Innovation Center (CMMI) announced the rollout of its long-awaited Oncology Care Model (OCM)—a payment model that includes financial and performance accountability for episodes of care (EOC) with regards to chemotherapy administration to patients with cancer. The goals of the OCM are part of the Department of Health and Human Service’s initiative to link payments to quality care, improvement in care delivery, and sharing information more broadly to support better decision making. Financial incentives are based on a 6-month chemotherapy EOC, and participating practices will receive monthly care management payments for each Medicare fee-for-service beneficiary during an EOC.
OBR interviewed several stakeholders on how they received the OCM and what they think are the pros and cons of the model.
Read the article here:
Listen to Ira Klein, MD,MBA, n
ational medical director, Clinical Thought Leadership, Aetna speak to AJMC about the OCM
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
